0001325812-15-000052.txt : 20150618
0001325812-15-000052.hdr.sgml : 20150618
20150618163837
ACCESSION NUMBER: 0001325812-15-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150616
FILED AS OF DATE: 20150618
DATE AS OF CHANGE: 20150618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vaishnaw Akshay
CENTRAL INDEX KEY: 0001458494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 15940538
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-06-16
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001458494
Vaishnaw Akshay
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
EVP, R&D, CMO
Common Stock
2015-06-16
4
M
0
6250
9.3
A
6250
D
Common Stock
2015-06-16
4
M
0
2500
7.1
A
8750
D
Common Stock
2015-06-16
4
S
0
3933
128.0983
D
4817
D
Common Stock
2015-06-16
4
S
0
2667
128.7885
D
2150
D
Common Stock
2015-06-16
4
S
0
1800
130.0554
D
350
D
Common Stock
2015-06-16
4
S
0
350
130.9986
D
0
D
Common Stock
103
I
by Managed Account
Stock Option (right to buy)
7.1
2015-06-16
4
M
0
2500
0
D
2021-11-30
Common Stock
2500
5000
D
Stock Option (right to buy)
9.3
2015-06-16
4
M
0
6250
0
D
2021-06-09
Common Stock
6250
0
D
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2013
Sale prices ranged from $127.49 to $128.46.
Sale prices ranged from $128.49 to $129.38.
Sale prices ranged from $129.55 to $130.50.
Sale prices ranged from $130.57 to $131.22.
The reporting person owns 103 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
/s/ Michael P. Mason, Attorney-in-Fact for Akshay K. Vaishnaw
2015-06-18